Back to search

Article

Sex-Specific Gene Expression in MASLD: A Transcriptomic and Systems Biology Analysis Reveals Key Regulatory Modules and Immune Networks

2026-03-18

Abstract excerpt

<title>Abstract</title> <p> Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex metabolic disorder disease characterized by significant sex-related differences in its pathogenesis and progression. Elucidating the sex-specific molecular mechanisms of MASLD is crucial for identifying novel therapeutic targets. Methods We analyzed liver gene expression profiles from MASLD pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
680f2593-69b2-5e1d-8aed-958d68be763d
DOI
10.21203/rs.3.rs-9063561/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sex-Specific Gene Expression in MASLD: A Transcriptomic and Systems Biology Analysis Reveals Key Regulatory Modules and Immune NetworksDOI 10.21203/rs.3.rs-9063561/v1
Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progressionSemantic proximity
Integrative multi-omics and multi-trait analysis prioritizes regulatory mechanisms and genes for metabolic dysfunction-associated steatotic liver diseaseSemantic proximity
Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learningSemantic proximity
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome AnalysisSemantic proximity
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity
Identification of EGR1 as a Key Diagnostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Through Machine Learning and Immune AnalysisSemantic proximity
Sex-specific lipid-mediated mechanisms drive MASLD progression revealed by paired liver–blood multi-omicsSemantic proximity
GSEA and the coexpression network approach identify novel pathway connections of molecular processes affected in Porto-sinusoidal vascular diseaseSemantic proximity
MegaMASLD: An interactive platform for exploring stratified transcriptomic signatures in MASLD progressionSemantic proximity
Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learningSemantic proximity
Immune and Metabolic Pathways in Idiopathic Membranous Nephropathy: Insights from Bioinformatics and Animal ModelsSemantic proximity
Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targetsSemantic proximity
Select a neighboring publication to make it the new centre.